bioRxivCancer BiologyPreprint
p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma
S. K. Hur, T. D. D. Somerville, X. S. Wu, D. Maia-Silva, O. E. Demerdash, D. A. Tuveson, F. Notta, C. R. Vakoc
Abstract
During the progression of pancreatic ductal adenocarcinoma (PDAC), tumor cells are known to acquire transcriptional and morphological properties of the basal (also known as squamous) epithelial lineage, which leads to more aggressive disease characteristics. Here, we show that a subset of basal-like PDAC tumors aberrantly express p73 (TA isoform), which is a known transcriptional activator of basal lineage identity, ciliogenesis, and tumor suppression in normal tissue development. Using gain- and loss- of function experiments, we show that p73 is necessary and sufficient to activate genes related to basal identity (e.g. KRT5), ciliogenesis (e.g. FOXJ1), and p53-like tumor suppression (e.g. CDKN1A) in human PDAC models. Owing to the paradoxical combination of oncogenic and tumor suppressive outputs of this transcription factor, we propose that PDAC cells express a low level of p73 that is optimal for promoting lineage plasticity without severe impairment of cell proliferation. Collectively, our study reinforces how PDAC cells exploit master regulators of the basal epithelial lineage during disease progression.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Marker-based CRISPR screening reveals a MED12-p63 interaction that activates basal identity in pancreatic ductal adenocarcinoma
D. Maia-Silva, A. C. Schier, … C. R. Vakoc·bioRxiv·Oct 24, 2023
- p53 and YAP/TAZ-TEAD activities determine metaplastic heterogeneity in pancreatic cancer
Cole P Martin, Scott Bang, … John P. Morris·bioRxiv·Dec 15, 2025
- WNT7B drives a program for pancreatic cancer subtype switching and progression
Joep Sprangers, Jeroen M. Bugter, … Madelon M. Maurice·iSciencePeer-reviewed·Feb 17, 2026
- Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
Jose Reyes, Isabella S. Del Priore, … Scott W. Lowe·CellPeer-reviewed·Apr 15, 2026
- Drug-Induced p53 Activation Limits Pancreatic Cancer Initiation
Jennifer J. Twardowski, Thomas I. Heist, … Stephano S. Mello·bioRxiv·May 29, 2024
- E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma
L. Bertonnier-Brouty, J. Andersson, … I. Artner·bioRxiv·Nov 10, 2023